8-K/A XBRL

FORM 8-K/A

Company: ZEVRA THERAPEUTICS, INC.
Filed: February 5, 2024
Period of Report: November 20, 2023
Accession Number: 0001437749-24-003003

View Document ↗ View on SEC.gov ↗